Recombinant Saccharomyces cerevisiae Eukaryotic translation initiation factor 3 subunit B (PRT1), partial

What is the structural composition of eIF3 in Saccharomyces cerevisiae and how does PRT1 fit into this complex?

In Saccharomyces cerevisiae, eIF3 is composed of five core essential subunits: a/TIF32, b/PRT1, c/NIP1, i/TIF34, and g/TIF35. This represents a simpler version compared to the mammalian eIF3 complex which contains 12 subunits. PRT1 (eIF3b) is one of these core components and is essential for cell viability .

The S. cerevisiae PRT1 protein has a molecular weight of approximately 88.1 kDa and contains specific domains including WD40 repeats and an RNA recognition motif (RRM). These structural elements are critical for its functionality within the eIF3 complex . The WD40 domains create a platform for protein-protein interactions, while the RRM domain mediates RNA binding and interactions with other translation factors.

What are the primary functions of the PRT1 subunit in translation initiation?

PRT1 plays several crucial roles in translation initiation:

• It serves as a scaffold protein within the eIF3 complex, helping to maintain structural integrity through interactions with other eIF3 subunits .

• Through its RNA recognition motif, PRT1 contributes to mRNA binding and recruitment to the 40S ribosomal subunit .

• It participates in the stabilization of the ternary complex (eIF2-GTP-tRNAᴹᵉᵗᵢ) on the 40S ribosomal subunit .

• PRT1 helps coordinate the placement and functional conformations of other initiation factors on the surface of the small ribosomal subunit .

• It contributes to the scanning process and accurate start codon selection during initiation .

The central position of PRT1 in the eIF3 complex makes it essential for coordinating multiple steps in translation initiation.

How does recombinant PRT1 from yeast compare to its human homolog?

The human homolog of yeast PRT1 (known as hPrt1 or eIF3b) shares 31% identity and 50% similarity at the amino acid level with the yeast protein . This homology is distributed throughout the entire protein except for the amino terminus, with particularly high conservation in the central portion containing the RNA recognition motif .

Notable differences include:

• Human eIF3b has a predicted molecular mass of 98.9 kDa but migrates at 116 kDa on SDS-polyacrylamide gels .

• While yeast PRT1 interacts with a smaller set of eIF3 subunits, human eIF3b interacts with a more complex network of protein partners in the larger mammalian eIF3 complex .

• The RNA recognition motif is highly conserved and serves as the region required for association with the p170 subunit (eIF3a) in humans .

Despite these differences, the functional conservation of PRT1/eIF3b across species makes yeast an excellent model system for studying basic mechanisms of translation initiation.

What are the optimal expression systems for producing functional recombinant PRT1 protein?

Producing functional recombinant PRT1 requires careful consideration of expression systems to ensure proper folding and activity. Based on current research approaches:

E. coli Expression System:

• Advantages: High yield, cost-effective, rapid growth

• Limitations: May lack post-translational modifications, potential for inclusion body formation

• Optimization strategies: Use of specialized strains (BL21(DE3), Rosetta), lower induction temperatures (16-18°C), and co-expression with chaperones

Yeast Expression Systems:

• Advantages: Native post-translational modifications, proper folding environment

• Recommended strains: Protease-deficient strains (e.g., BJ5464)

• Induction conditions: 0.5-2% galactose for GAL promoter systems, 20-30°C for optimal expression

Insect Cell Systems:

• Advantages: Higher eukaryotic processing, suitable for complex proteins

• Recommended: Baculovirus expression with Sf9 or High Five cells

• Optimization: MOI 1-5, harvest at 48-72 hours post-infection

For functional studies of PRT1 within the entire eIF3 complex, co-expression strategies have been employed successfully. Recent advances have shown that the entire 13-subunit human eIF3 complex can be reconstituted in E. coli, suggesting similar approaches may work for the yeast complex .

What experimental approaches are most effective for studying PRT1 interactions within the eIF3 complex?

Several complementary approaches have proven effective for investigating PRT1 interactions:

Biochemical Methods:

• Co-immunoprecipitation using anti-PRT1 antibodies to pull down associated factors

• GST pull-down assays with recombinant PRT1 domains to map specific interaction regions

• Far Western blotting to detect direct protein-protein interactions, as demonstrated in studies showing direct interaction between human Prt1 and the p170 subunit

Structural Biology Approaches:

In vivo Methods:

• Yeast two-hybrid screening for identifying novel interaction partners

• Fluorescence microscopy with tagged PRT1 variants to track localization

• FRET/BRET assays to monitor real-time interactions in living cells

Domain Mapping:
When investigating specific interactions, domain mapping studies have identified the RNA recognition motif of PRT1 as particularly important for association with other eIF3 subunits . Truncation constructs targeting specific domains (WD40 repeats, RRM, etc.) can help delineate the functional contributions of each region.

How can one design site-directed mutagenesis experiments to investigate critical residues in PRT1 function?

Effective site-directed mutagenesis of PRT1 requires strategic planning based on evolutionary conservation, structural information, and previous functional data:

Target Selection Strategy:

• Identify highly conserved residues by multiple sequence alignment of PRT1 homologs across species

• Focus on residues within functional domains (RRM, WD40 repeats)

• Prioritize charged or aromatic residues at predicted protein-protein interfaces

• Consider residues implicated in RNA binding within the RRM domain

Mutation Type Selection:

• Alanine scanning: Replace targeted residues with alanine to remove side chain interactions while maintaining backbone structure

• Conservative substitutions: Maintain chemical properties (e.g., Lys→Arg) to test charge importance

• Non-conservative substitutions: Change chemical properties (e.g., Lys→Glu) to test charge reversal effects

• Domain swapping: Replace domains with corresponding regions from other species to test evolutionary conservation of function

Functional Validation Methods:

• In vitro translation assays to measure initiation efficiency

• 40S ribosome binding assays to assess recruitment activity

• RNA binding assays to evaluate substrate recognition

• Complementation of prt1 null mutations in yeast to assess in vivo functionality

When designing mutations within the RNA recognition motif, particular attention should be paid to the RNP1 and RNP2 motifs, which typically contain highly conserved aromatic residues crucial for RNA binding.

What are common obstacles when purifying recombinant PRT1, and how can they be overcome?

Purification of recombinant PRT1 presents several challenges that researchers frequently encounter:

Challenge 1: Poor Solubility

• Solution: Optimize expression conditions (lower temperature, reduced inducer concentration)

• Add solubility tags (MBP, SUMO, TrxA) followed by on-column cleavage

• Screen different buffer conditions (pH 7.0-8.0, 150-500 mM NaCl, 5-10% glycerol)

• Include mild detergents (0.05-0.1% Triton X-100 or NP-40) during lysis

Challenge 2: Proteolytic Degradation

• Solution: Add protease inhibitor cocktails during all purification steps

• Reduce purification time by optimizing protocols

• Use protease-deficient expression strains

• Include EDTA (1-5 mM) to inhibit metalloproteases if compatible with downstream applications

Challenge 3: Co-purifying Contaminants

• Solution: Implement multi-step purification strategy (affinity + ion exchange + size exclusion)

• Increase washing stringency during affinity purification

• Include ATP wash steps (5-10 mM ATP, 10 mM MgCl₂) to remove chaperone contaminants

• Use gradient elution during ion exchange chromatography

Challenge 4: Loss of Activity During Purification

• Solution: Maintain reducing conditions (1-5 mM DTT or 2-10 mM β-mercaptoethanol)

• Add stabilizing agents (10% glycerol, 100-200 mM L-arginine)

• Test stability with thermal shift assays to optimize buffer conditions

• Consider purifying entire eIF3 complex instead of isolated PRT1

For researchers specifically interested in studying PRT1 within the intact eIF3 complex, co-expression and co-purification strategies have proven more successful than reconstitution from individually purified components .

How can researchers troubleshoot functional assays involving recombinant PRT1?

When functional assays with recombinant PRT1 fail to produce expected results, several troubleshooting approaches can be employed:

In vitro Translation Assays:

• Problem: Low activity of purified PRT1

• Solutions:

  • Verify protein folding using circular dichroism or limited proteolysis

  • Ensure all required cofactors are present (other eIF3 subunits, ATP, GTP)

  • Check RNA quality and integrity

  • Optimize salt concentration (typically 100-150 mM KCl optimal)

  • Include RNase inhibitors to prevent RNA degradation

Ribosome Binding Assays:

• Problem: Poor binding of PRT1 to 40S ribosomes

• Solutions:

  • Pre-clear ribosomal preparations to remove aggregates

  • Include low concentrations of Mg²⁺ (2-3 mM) to stabilize interactions

  • Verify ribosome integrity by analyzing rRNA on agarose gels

  • Use freshly prepared ribosomes or store at -80°C with cryoprotectants

  • Ensure PRT1 is properly folded with intact interaction domains

RNA Binding Assays:

• Problem: Weak or nonspecific RNA binding

• Solutions:

  • Optimize RNA:protein ratios

  • Test different binding buffers (varying salt, pH, and divalent cations)

  • Consider the need for other eIF3 subunits for specific RNA recognition

  • Use competition assays with unlabeled RNA to verify specificity

  • Include non-specific competitors (tRNA, heparin) to reduce background

Protein-Protein Interaction Assays:

• Problem: Failure to detect PRT1 interactions with other eIF3 subunits

• Solutions:

  • Optimize detergent conditions to preserve interactions while solubilizing proteins

  • Use zero-length or short crosslinkers to capture transient interactions

  • Include stabilizing agents (10% glycerol, 100 mM L-arginine)

  • Ensure proper tagging position (N- vs C-terminal) to avoid blocking interaction sites

How can structural studies of PRT1 contribute to understanding translation initiation mechanics?

Structural investigations of PRT1 provide critical insights into translation initiation mechanisms:

Cryo-EM Applications:

• High-resolution structures of PRT1 within the eIF3 complex bound to the 40S ribosomal subunit reveal the spatial organization and interactions during initiation

• Time-resolved cryo-EM can capture different conformational states during the initiation process

• Focused classification methods can resolve flexible regions of PRT1 that may undergo conformational changes

Integrative Structural Biology Approach:

• Combining X-ray crystallography of individual domains with cryo-EM of larger assemblies

• Using crosslinking mass spectrometry (XL-MS) to identify proximity relationships

• Implementing molecular dynamics simulations to study dynamic conformational changes

• Applying hydrogen-deuterium exchange mass spectrometry to map solvent-accessible regions and binding interfaces

Structure-Function Correlations:
Structural data enable hypothesis-driven experiments to connect PRT1 architecture with specific functions. For example, understanding how the RNA recognition motif of PRT1 interacts with the p170 subunit of eIF3 provides insight into how the complex assembles and functions.

The negative-stain EM reconstructions of reconstituted eIF3 have revealed how the structural core (including PRT1) organizes the highly flexible 800 kDa molecular mass eIF3 complex and mediates translation initiation . This structural information guides the design of targeted experiments to further elucidate initiation mechanisms.

What techniques are available for monitoring PRT1 dynamics during translation initiation in real-time?

Recent advancements have enabled researchers to observe PRT1 dynamics during translation processes:

Single-Molecule Fluorescence Techniques:

• Single-molecule FRET (smFRET) with strategically placed fluorophores on PRT1 and interaction partners

• Setup: Total internal reflection fluorescence (TIRF) microscopy with immobilized ribosomes or eIF3 complexes

• Analysis: Hidden Markov modeling to identify discrete conformational states

• Application: Monitoring conformational changes in PRT1 during mRNA recruitment and scanning

Time-Resolved Cryo-EM:

• Rapid mixing and freezing at defined time points after initiation

• Microfluidic devices for precise reaction timing before vitrification

• Classification of structural states to build temporal models of PRT1 conformational changes

Mass Photometry:

• Label-free technique to monitor assembly and disassembly of complexes containing PRT1

• Advantages: Native conditions, single-molecule sensitivity, real-time measurements

• Applications: Measuring binding kinetics of PRT1 with other eIF3 subunits or with the ribosome

Fluorescence Correlation Spectroscopy (FCS):

• Measuring diffusion rates of fluorescently labeled PRT1 to detect complex formation

• Advantages: Solution-based measurements, requires minimal sample amounts

• Applications: Determining binding constants and association/dissociation rates

These techniques can reveal how PRT1 and the eIF3 complex dynamically associate with and dissociate from the ribosome during different phases of translation initiation, scanning, termination, and recycling .

How can recombinant PRT1 be used to study translational control mechanisms in disease models?

Recombinant PRT1 provides valuable tools for investigating translational dysregulation in disease:

Cancer Research Applications:

• Comparing PRT1 interactions with wild-type and oncogenic mRNAs to understand selective translation

• Investigating how PRT1 contributes to the eIF3 role in selective mRNA translation, particularly for transcripts involved in cell cycle, apoptosis, and differentiation

• Developing assays to screen for compounds that modify aberrant PRT1-mediated translation

Viral Infection Studies:

• Using reconstituted systems with PRT1/eIF3 to study viral internal ribosome entry site (IRES) mechanisms

• Investigating how hepatitis C virus (HCV) IRES RNA interacts with eIF3 components including PRT1

• Testing antiviral compounds that target PRT1-viral RNA interactions

Neurodegenerative Disease Models:

• Examining how PRT1 contributes to the translation of proteins involved in neurodegeneration

• Studying effects of disease-associated mutations in translation factors that interact with PRT1

• Developing assays to identify compounds that restore normal translation patterns

Methodological Approaches:

• Reconstituted in vitro translation systems with purified components including recombinant PRT1

• CRISPR-engineered cell lines expressing modified PRT1 to study disease-relevant translation

• RNA-protein interaction assays to identify disease-specific binding patterns

• Ribosome profiling combined with PRT1 variant expression to assess translational impacts

What are the key structural and functional differences between yeast PRT1 and its mammalian homologs?

Understanding the differences between yeast and mammalian PRT1 homologs provides insights into evolutionary conservation and specialization of translation mechanisms:

Functional Divergence:

• Mammalian eIF3b/hPrt1 participates in more complex regulatory networks than yeast PRT1

• The human eIF3 complex has acquired additional roles in selective mRNA translation not observed in yeast

• Yeast PRT1 functions primarily in basic translation initiation, while mammalian homologs have expanded roles in translational control

Despite these differences, the core functions in translation initiation remain highly conserved, making yeast PRT1 an excellent model for studying fundamental translation mechanisms.

How can evolutionary analysis of PRT1 inform functional studies?

Evolutionary analysis provides powerful insights for designing experiments and interpreting results:

Sequence Conservation Analysis:

• Multiple sequence alignment of PRT1 homologs across evolutionary distances reveals highly conserved residues likely critical for function

• Conservation mapping onto structural models identifies functional surfaces and interfaces

• Rates of evolutionary change in different domains suggest differential selective pressures and functional constraints

Experimental Applications:

• Design mutagenesis experiments targeting ultraconserved residues

• Identify species-specific features for functional testing

• Guide the development of chimeric proteins to assess domain function across species

• Predict functionally important post-translational modification sites based on conservation

Coevolution Analysis:

• Identify coordinated evolutionary changes between PRT1 and interacting partners

• Predict residue pairs involved in protein-protein interactions

• Guide crosslinking experiments to verify predicted interaction sites

Functional Testing Strategies:

• Complementation assays testing whether human eIF3b can rescue yeast prt1 mutants

• Domain swapping experiments to identify species-specific functional regions

• Evolutionary rate analysis to prioritize regions for detailed functional characterization

Understanding evolutionary patterns in PRT1 helps researchers focus on the most functionally significant aspects of this translation factor and design more targeted, hypothesis-driven experiments.

What are the most reliable antibodies and detection methods for PRT1 in experimental systems?

Selecting appropriate detection tools is critical for successful PRT1 research:

Antibody Selection Guidelines:

• Commercial anti-PRT1 antibodies vary in specificity and applications

• Polyclonal antibodies offer higher sensitivity but potential cross-reactivity

• Monoclonal antibodies provide higher specificity but may be less sensitive

• Epitope location can affect detection of PRT1 in complexes if binding sites are masked

Recommended Detection Approaches:

• Western blotting: Optimized SDS-PAGE conditions (7.5-10% gels) to resolve the full-length protein

• Immunoprecipitation: Use of magnetic beads with covalently coupled antibodies to reduce background

• Immunofluorescence: Fixation optimization (4% paraformaldehyde usually preferred over methanol)

• Flow cytometry: Permeabilization protocols must be optimized for intracellular detection

Alternative Detection Strategies:

Controls and Validation:

• Include positive controls (purified recombinant protein)

• Negative controls (prt1 knockout/knockdown samples)

• Validate specificity with competing peptides or alternative antibodies

• Confirm reactivity against both native and denatured forms if needed

Research has shown that antibodies raised against eIF3 can recognize hPrt1, and affinity-purified antibodies to recombinant hPrt1 can recognize a protein migrating at 116 kDa in purified eIF3 preparations .

What advanced computational methods are useful for analyzing PRT1 structure-function relationships?

Computational approaches enhance experimental studies of PRT1:

Structural Prediction Methods:

• AlphaFold2 and RoseTTAFold for predicting 3D structures of PRT1 and domains

• Molecular dynamics simulations to assess conformational flexibility

• Normal mode analysis to identify functionally relevant motions

• Docking algorithms to predict interactions with RNA, ribosome, and other eIF3 subunits

Sequence Analysis Tools:

• HMMER profiles for detecting distant homologs and domain boundaries

• ConSurf for mapping evolutionary conservation onto structural models

• Coevolution analysis (DCA, GREMLIN) to predict residue-residue contacts

• SignalP, NetPhos for predicting post-translational modifications

Network Analysis:

• Protein-protein interaction network modeling

• Integration of experimental data (crosslinking, co-IP) with computational predictions

• Community detection algorithms to identify functional modules

• Perturbation simulations to predict effects of mutations

Machine Learning Applications:

• Prediction of binding sites using deep learning approaches

• Classification of functional effects of mutations

• Integration of multiple data types (sequence, structure, expression) for functional annotation

These computational approaches can help guide experimental design, interpret results, and generate new hypotheses about PRT1 function that can be experimentally tested.

What are emerging technologies that may advance PRT1 functional studies?

Several cutting-edge technologies show promise for transforming PRT1 research:

Cryo-Electron Tomography:

• Visualizing PRT1/eIF3 in cellular context without artificial reconstitution

• Combining with focused ion beam milling for in situ structural studies

• Correlative light and electron microscopy to track specific translation events

Advanced Mass Spectrometry:

• Crosslinking mass spectrometry at single-residue resolution

• Native mass spectrometry to determine complex stoichiometry and assembly

• Targeted proteomics for quantifying PRT1 modifications and interactions

Gene Editing Technologies:

• CRISPR base editing for precise point mutations in endogenous PRT1

• CRISPR activation/repression systems for controlled expression

• Auxin-inducible degron tags for rapid, reversible protein depletion

Synthetic Biology Approaches:

• De novo design of minimal PRT1 variants with specific functions

• Orthogonal translation systems incorporating engineered PRT1

• Cell-free expression systems with defined components for mechanistic studies

Spatial Transcriptomics/Proteomics:

• Mapping local translation events mediated by PRT1/eIF3

• Correlating PRT1 localization with translation activity

• Single-cell analysis of translation regulation variations

These emerging technologies will enable researchers to address previously inaccessible questions about PRT1 function and regulation in translation initiation.

What unresolved questions about PRT1 represent important areas for future investigation?

Despite significant progress, several key questions about PRT1 remain unanswered:

Structural Questions:

• What is the atomic-resolution structure of full-length PRT1 within the eIF3 complex?

• How does PRT1 conformation change during different stages of translation?

• What are the precise interaction interfaces between PRT1 and other translation components?

Functional Questions:

• How does PRT1 contribute to selective mRNA translation?

• What is the exact role of PRT1 in scanning and start codon selection?

• How does PRT1 participate in translation termination and ribosome recycling ?

• What post-translational modifications regulate PRT1 activity?

Regulatory Questions:

• How is PRT1 expression and activity regulated under different cellular conditions?

• Does PRT1 have translation-independent functions in the cell?

• How do disease states affect PRT1 function and translation regulation?

Evolutionary Questions:

• Why has the eIF3 complex expanded in mammals compared to yeast, and how has this affected PRT1 function?

• What selective pressures have shaped PRT1 evolution across eukaryotes?

• How did the functional interaction between PRT1 and viral translation elements evolve?

Addressing these questions will require integrating advanced structural, biochemical, genetic, and computational approaches to build a comprehensive understanding of this essential translation factor.

How does current PRT1 research fit into the broader context of translation regulation studies?

PRT1 research has significantly contributed to our understanding of translation regulation at multiple levels:

Mechanistic Insights:
Research on PRT1 has revealed fundamental aspects of translation initiation machinery assembly and function. The identification of PRT1's role within the eIF3 complex has helped elucidate how eukaryotic cells achieve precise control over protein synthesis .

Evolutionary Perspective:
Comparative studies between yeast PRT1 and its mammalian homologs have illuminated both conserved core functions and species-specific adaptations in translation machinery . This evolutionary lens provides insight into the fundamental requirements for translation versus specialized regulatory mechanisms.

Disease Relevance:
Understanding PRT1's role in translation has implications for numerous diseases where translation dysregulation occurs, including cancer, viral infections, and neurodegenerative disorders. Research on how viruses like HCV interact with eIF3 components has highlighted the importance of translation factors as potential therapeutic targets .

Technical Advances:
Methods developed for studying PRT1, such as reconstitution of the entire eIF3 complex , have broader applications in studying complex macromolecular assemblies. These technical innovations benefit the wider field of molecular biology and biochemistry.

As research continues, PRT1 studies will likely contribute to emerging areas such as:

• Specialized ribosomes and customized translation

• RNA modification effects on translation regulation

• Targeted therapeutics for translation-related diseases

• Synthetic biology applications of engineered translation systems